93M1 Stock Overview
An investment company, engages in the healthcare business in Germany.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
MPH Health Care AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €32.60 |
| 52 Week High | €36.20 |
| 52 Week Low | €13.65 |
| Beta | 1.16 |
| 1 Month Change | 23.48% |
| 3 Month Change | 39.91% |
| 1 Year Change | 108.97% |
| 3 Year Change | 8.31% |
| 5 Year Change | -21.07% |
| Change since IPO | 40.39% |
Recent News & Updates
Recent updates
MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 30%
Jun 13
Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)
Sep 15A Look At The Fair Value Of MPH Health Care AG (FRA:93M1)
Sep 02We're Interested To See How MPH Health Care (FRA:93M1) Uses Its Cash Hoard To Grow
Oct 02We're Not Worried About MPH Health Care's (FRA:93M1) Cash Burn
Jun 19Shareholder Returns
| 93M1 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -2.4% | -0.7% | -3.1% |
| 1Y | 109.0% | -18.1% | -0.5% |
Return vs Industry: 93M1 exceeded the German Pharmaceuticals industry which returned -18.1% over the past year.
Return vs Market: 93M1 exceeded the German Market which returned -0.5% over the past year.
Price Volatility
| 93M1 volatility | |
|---|---|
| 93M1 Average Weekly Movement | 9.7% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 93M1's share price has been volatile over the past 3 months.
Volatility Over Time: 93M1's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 2 | Patrick Brenske | www.mph-ag.de |
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. The company operates Beauty, Pharma, and Real Estate segments. It offers medicalaesthetic beauty operations and treatments, as well as the operation and provision of medical infrastructures for partner companies; and pharmaceuticals and medical products in the therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine.
MPH Health Care AG Fundamentals Summary
| 93M1 fundamental statistics | |
|---|---|
| Market cap | €139.57m |
| Earnings (TTM) | €29.54m |
| Revenue (TTM) | €34.43m |
4.7x
P/E Ratio4.1x
P/S RatioIs 93M1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 93M1 income statement (TTM) | |
|---|---|
| Revenue | €34.43m |
| Cost of Revenue | €0 |
| Gross Profit | €34.43m |
| Other Expenses | €4.89m |
| Earnings | €29.54m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 05, 2024
| Earnings per share (EPS) | 6.90 |
| Gross Margin | 100.00% |
| Net Profit Margin | 85.81% |
| Debt/Equity Ratio | 3.3% |
How did 93M1 perform over the long term?
See historical performance and comparison